The use of recombinant activated factor VII for controlling life-threatening bleeding in Dengue Shock Syndrome

• المؤلفون الرئيسيون: Chuansumrit A., Tangnararatchakit K., Lektakul Y., Pongthanapisith V., Nimjaroenniyom N., Thanarattanakorn P., Wongchanchailert M., Komwilaisak P.
• التنسيق: مقال
• اللغة: English
• منشور في: 2014
• الوصول للمادة أونلاين: http://www.scopus.com/inward/record.url?eid=2-s2.0-2942615463&partnerID=40&md5=298770d06fed53822f12b8e523feb02a; http://cmuir.cmu.ac.th/handle/6653943832/4134

To report the use of recombinant activated factor VII (rFVIIa) in controlling life-threatening bleeding episodes in patients with grades III and IV Dengue Hemorrhagic Fever (DHF), also known as Dengue Shock Syndrome. Fifteen patients (seven boys, eight girls), whose median age was 8 years, were enro...